Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas
Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers
Tags: 3-MT, dopamine metabolite, homovanillic acid (HVA) precursor, human TAAR1 agonist, human trace amine
BASi Method Number SAP.1884
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
